Vitamin D therapy

Current Osteoporosis Reports

Volumn 6, Issue 1, 2008, Pages 5-11

  Geller, Jordan L ^b   Adams, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIDIOL 1 MONOOXYGENASE; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; RISEDRONIC ACID; VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE;

ABDOMINAL CRAMP; BONE DENSITY; BONE TURNOVER; CANCER RISK; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DEHYDRATION; DIET SUPPLEMENTATION; DRUG CLEARANCE; DRUG DETERMINATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; ENZYME BLOOD LEVEL; EPIDEMIC; EVIDENCE BASED PRACTICE; GENETIC TRANSCRIPTION; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; INTOXICATION; MALAISE; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIMARY PREVENTION; QUANTITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SUN EXPOSURE; TREATMENT DURATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEAKNESS; BLOOD; DOSE RESPONSE;

BONE DENSITY CONSERVATION AGENTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOPOROSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 44849144081     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-008-0002-z     Document Type: Review

References (43)

1. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006, 116:2062-2072.
2. Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases. JAMA 2004, 292:490-495.
3. Kumaravel R: Vitamin D, cod-liver oil, sunlAght, and rickets: a historical perspective. Pediatrics 2003, 112:e132-e135.
4. Moore CE, Murphy MM, Holick MF: Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr 2005, 135:2478-2485.
5. Taha SA, Dost SM, Sedrani SH: 25-hydroxy-vitamin D and total calcium: extraordinarily low plasma concentrations in Saudi mothers and their neonates. Pediatr Res 1984, 18:739-741.
6. Matsuoka LY, Ide L, Wortsman J, et al.: Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987, 64:1165-1168.
7. MacLaughlin J, Holick MF: Vitamin D requirements for the elderly. Clin Nutr 1986, 5:121-129.
8. World Health Organization: Expert committee on biological standardization, report of the subcommittee on fat soluble vitamins. World Health Organ Tech Rep Ser 1950, 3: 7.
9. Heaney RP: Long-latency defIciency disease: insights from calcium and vitamin D. Am J Clin Nutr 2003, 78:912-919.
10. Holick MF, Shao Q, Liu WW, Chen TC: The vitamin D content of fortified milk and infant formula. N Engl J Med 1992, 326:1178-1181.
11. Abbasi AA, Amin M, Smiertka JK, et al.: Abnormalities of vitamin D and calcium metabolism after surgical treatment of morbid obesity: A study of 136 patients. Endocr Pract 2007, 13:131-136.
12. Holick MF, Adams JA: Vitamin D metabolism and biological function. In Metabolic Bone Disease, edn 3. Edited by Avioli LV, Krane SM. New York: Academic Press; 1997:124-164.
13. Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
14. Harris SS, Dawson-Hughes B: Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr 2002, 21:357-362.
15. Binkley N, Krueger D, Cowgill CS, et al.: Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization. J Clin Endocrinol Metab 2004, 89:3152-3157.
16. Heaney RP: Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80:1706S-1709S.
17. Lips P, Duong T, Oleksik A, et al.: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2001, 86:1212-1221.
18. Sahota O, Mundey MK, San P, et al.: The relationship between vitamin D and parathyroid hormone, calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004, 35:312-319.
19. Holick MF, Siris ES, Binkley N, et al.: Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215-3224.
20. Jackson RD, LaCroix AZ, Gass M, et al.: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683.
21. Geller JL, Adams JS: Repair of vitamin D insufficiency increases bone mass in bisphosphonate-treated patients. Endocr Pract 2007, In press.
22. Chapuy MC, Pampile R, Paris E, et al.: Combined calcium and vitamin D3 supplementation to prevent hip fracture in elderly women. A confirmatory study: Decalyos II. Osteoporos Int 2002, 13:S25.
23. Chapuy MC, Arlot ME, Duboeuf F, et al.: Vitamin D and calcium to prevent hip fractures in elderly women. N Engl J Med 1992, 327:1637-1642.
24. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670-676.
25. Trivedi DP, Doll R, Tee Khaw K: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomized double blind controlled trial. BMJ 2002, 326:469-474.
26. Lips P, Graafmans WC, Ooms ME, et al.: Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 1996, 124:400-406.
27. Meyer HE, Smedshaug GB, Kvaavik E, et al.: Can vitamin D supplementation reduce the risk of fracture in the elderly? J Bone Miner Res 2002, 17:891-897.
28. Bischoff-Ferrari HA, Willett WC, Wong JB, et al.: Fracture prevention with vitamin D supplementation: A metaanalysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
29. Grey A, Lucas J, Horne A, et al.: Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005, 90:2122-2126.
30. Kantorovich V, Gacad MA, Seeger LL, Adams JS: Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: P3541-3543.
31. Harris ST, Watts NB, Genant HK, et al.: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. JAMA 1999, 282:1344-1352.
32. Black DM, Thompson DE, Bauer DC, et al.: Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000, 85:4118-4124.
33. Merck & Co. Inc.: 25-hydroxyvitamin D levels after treatment with FOSAMAX PLUS D (70 mg/2800 IU) or FOSAMAX 70 mg. Fosamax plus D prescribing information. Whitehouse Station, NJ: Merck & Co. Inc.; 2006.
34. Adams JS, Kantorovich V, Wu C, et al.: Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999, 84:2729-2730.
35. National Osteoporosis Foundation: Updated recommendations for calcium and vitamin D intake. Available at http://www.nof.org/prevention/ calciumandVitaminD.htm. Accessed October 22, 2007.
36. Adams JS, Clemens TL, Parrish JA, Holick MF: Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med 1982, 306:722-725.
37. Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endo Rev 2001, 22:477-501.
38. Heaney RP, Davies KM, Chen TC, et al.: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
39. Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
40. Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
41. Adams JS, Lee GE: Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997, 127:203-206.
42. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al.: Effect of vitamin D on falls: A meta-analysis. JAMA 2004, 291:1999-2006.
43. Lappe M, Travers-Gustafson D, Davies KM, et al.: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.